HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Brooke, C. J. Articles by Hampson, D. J. Search for Related Content PubMed PubMed Citation Articles by Brooke, C. J. Articles by Hampson, D. J. Agricola Articles by Brooke, C. J. Articles by Hampson, D. J.

Evaluation of selective media for the isolation of Brachyspira aalborgi from human faeces

¹Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia 6150, Australia ^2,3Division of Microbiology and Infectious Diseases, The Western Australian Centre of Pathology and Medical Research² and Department of Microbiology, The University of Western Australia³, Nedlands, Western Australia 6009, Australia#dReceived 5 November 2002 Accepted 2 March 2003

Correspondence: David J. Hampson (d.hampson{at}murdoch.edu.au)

The purposes of this study were to identify a solid medium that supports improved growth of the anaerobic intestinal spirochaete Brachyspira aalborgi, to modify this for use as a selective isolation medium and then to test the medium for its effectiveness in isolating B. aalborgi from patients’ faeces. Of the media evaluated, brain heart infusion agar (BHIA) with 10 % bovine blood (BB) was the most effective base–supplement combination for growth, with colonies attaining 1.2 mm in diameter by 21 days. Incubation in an anaerobic jar (94 % H₂, 6 % CO₂) permitted growth of larger colonies than incubation in an anaerobic chamber (80 % N₂, 10 % H₂, 10 % CO₂). Growth was improved only slightly at 38.5 °C compared with 37 °C. Selection of B. aalborgi from artificially seeded faeces was achieved equally well on eight different solid media containing spectinomycin (400 µg ml^-1) alone or in combinations with polymyxin B (5 µg ml^-1), colistin (25 µg ml^-1) and rifampicin (12.5 µg ml^-1). By using BHIA 10 % BB with spectinomycin plus polymyxin B, B. aalborgi was isolated from one of five human faecal samples that were positive for B. aalborgi by PCR amplification. This is the first report of the isolation of B. aalborgi from human faeces.

This article has been cited by other articles:

				K. R. Margawani, I. D. Robertson, C. J. Brooke, and D. J. Hampson Prevalence, risk factors and molecular epidemiology of Brachyspira pilosicoli in humans on the island of Bali, Indonesia J. Med. Microbiol., April 1, 2004; 53(4): 325 - 332. [Abstract] [Full Text] [PDF]

				A. S.J. Mikosza, M. A. Munshi, and D. J. Hampson Analysis of genetic variation in Brachyspira aalborgi and related spirochaetes determined by partial sequencing of the 16S rRNA and NADH oxidase genes J. Med. Microbiol., April 1, 2004; 53(4): 333 - 339. [Abstract] [Full Text] [PDF]